Iridex Stock Performance
| IRIX Stock | USD 1.49 0.07 4.49% |
On a scale of 0 to 100, IRIDEX holds a performance score of 9. The company retains a Market Volatility (i.e., Beta) of 1.09, which attests to a somewhat significant risk relative to the market. IRIDEX returns are very sensitive to returns on the market. As the market goes up or down, IRIDEX is expected to follow. Please check IRIDEX's treynor ratio, as well as the relationship between the expected short fall and price action indicator , to make a quick decision on whether IRIDEX's current trending patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in IRIDEX are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating forward indicators, IRIDEX showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Is IRIDEX Corporation stock in correction or buying zone - Portfolio Value Report Low Risk Entry Point Guides - fcp.pa.gov.br | 11/05/2025 |
2 | IRIDEX Director Buys 27,312.29 in Stock | 11/18/2025 |
3 | Acquisition by Romeo Dizon of 5760 shares of IRIDEX at 0.96 subject to Rule 16b-3 | 11/20/2025 |
4 | Acquisition by Romeo Dizon of 500 shares of IRIDEX at 1.15 subject to Rule 16b-3 | 11/25/2025 |
5 | What drives IRIDEX Corporation stock price - Economic Indicators Overview Take Advantage of Momentum Stocks - earlytimes.in | 11/28/2025 |
6 | Acquisition by Romeo Dizon of 320 shares of IRIDEX at 0.93 subject to Rule 16b-3 | 12/02/2025 |
7 | Iridex Announces the Publication of an Independent Study Demonstrating Safe and Effective Retreatment with Transscleral Laser Treatment Using MicroPulse Technol... | 12/11/2025 |
8 | Acquisition by Romeo Dizon of 2365 shares of IRIDEX at 0.9709 subject to Rule 16b-3 | 12/12/2025 |
9 | Acquisition by Moore William M of 20000 shares of IRIDEX subject to Rule 16b-3 | 12/15/2025 |
10 | Acquisition by Moore William M of 2000 shares of IRIDEX at 1.0099 subject to Rule 16b-3 | 12/16/2025 |
11 | Zacks Initiates Coverage of Iridex With Neutral Recommendation | 01/02/2026 |
12 | Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2025 | 01/12/2026 |
13 | Acquisition by Romeo Dizon of 227 shares of IRIDEX at 1.38 subject to Rule 16b-3 | 01/16/2026 |
14 | Acquisition by Romeo Dizon of 2100 shares of IRIDEX at 1.4987 subject to Rule 16b-3 | 01/20/2026 |
15 | Acquisition by Romeo Dizon of 409 shares of IRIDEX at 1.53 subject to Rule 16b-3 | 01/21/2026 |
| Begin Period Cash Flow | 7 M | |
| Total Cashflows From Investing Activities | -13 K |
IRIDEX Relative Risk vs. Return Landscape
If you would invest 106.00 in IRIDEX on October 25, 2025 and sell it today you would earn a total of 43.00 from holding IRIDEX or generate 40.57% return on investment over 90 days. IRIDEX is currently generating 0.7315% in daily expected returns and assumes 5.844% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than IRIDEX, and 86% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
IRIDEX Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for IRIDEX's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as IRIDEX, and traders can use it to determine the average amount a IRIDEX's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average IRIDEX is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IRIDEX by adding it to a well-diversified portfolio.
IRIDEX Fundamentals Growth
IRIDEX Stock prices reflect investors' perceptions of the future prospects and financial health of IRIDEX, and IRIDEX fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on IRIDEX Stock performance.
| Return On Equity | -1.39 | ||||
| Return On Asset | -0.0653 | ||||
| Profit Margin | (0.10) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 32.37 M | ||||
| Shares Outstanding | 16.99 M | ||||
| Price To Earning | (6.30) X | ||||
| Price To Book | 331.20 X | ||||
| Price To Sales | 0.51 X | ||||
| Revenue | 48.67 M | ||||
| Gross Profit | 19.34 M | ||||
| EBITDA | (6.88 M) | ||||
| Net Income | (8.91 M) | ||||
| Cash And Equivalents | 17.97 M | ||||
| Cash Per Share | 1.12 X | ||||
| Total Debt | 4.64 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.19 X | ||||
| Book Value Per Share | (0.08) X | ||||
| Cash Flow From Operations | (7.29 M) | ||||
| Earnings Per Share | (0.32) X | ||||
| Market Capitalization | 15.08 M | ||||
| Total Asset | 29.14 M | ||||
| Retained Earnings | (88.01 M) | ||||
| Working Capital | 7 M | ||||
| Current Asset | 30.77 M | ||||
| Current Liabilities | 7.43 M | ||||
About IRIDEX Performance
Evaluating IRIDEX's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if IRIDEX has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IRIDEX has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 155.67 | 188.55 | |
| Return On Tangible Assets | (0.38) | (0.36) | |
| Return On Capital Employed | (0.76) | (0.72) | |
| Return On Assets | (0.35) | (0.33) | |
| Return On Equity | (4.89) | (4.64) |
Things to note about IRIDEX performance evaluation
Checking the ongoing alerts about IRIDEX for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for IRIDEX help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| IRIDEX is way too risky over 90 days horizon | |
| IRIDEX may become a speculative penny stock | |
| IRIDEX appears to be risky and price may revert if volatility continues | |
| IRIDEX has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 48.67 M. Net Loss for the year was (8.91 M) with profit before overhead, payroll, taxes, and interest of 19.34 M. | |
| IRIDEX currently holds about 17.97 M in cash with (7.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.12. | |
| IRIDEX has a poor financial position based on the latest SEC disclosures | |
| Roughly 28.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Acquisition by Romeo Dizon of 409 shares of IRIDEX at 1.53 subject to Rule 16b-3 |
- Analyzing IRIDEX's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether IRIDEX's stock is overvalued or undervalued compared to its peers.
- Examining IRIDEX's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating IRIDEX's management team can have a significant impact on its success or failure. Reviewing the track record and experience of IRIDEX's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of IRIDEX's stock. These opinions can provide insight into IRIDEX's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for IRIDEX Stock Analysis
When running IRIDEX's price analysis, check to measure IRIDEX's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IRIDEX is operating at the current time. Most of IRIDEX's value examination focuses on studying past and present price action to predict the probability of IRIDEX's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IRIDEX's price. Additionally, you may evaluate how the addition of IRIDEX to your portfolios can decrease your overall portfolio volatility.